Therapeutic Interventions for Tone Abnormalities in Cerebral Palsy

NeuroRx

Volumn 3, Issue 2, 2006, Pages 217-224

  Tilton, Ann H ^a  

^a Department of Pathology   (United States)

Author keywords

botulinum toxin; Cerebral palsy; intrathecal baclofen; orthopedic surgery; selective dorsal rhizotomy; spasticity

Indexed keywords

ALCOHOL; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CLONAZEPAM; DANTROLENE; DIAZEPAM; PHENOL; TIZANIDINE; ANTIPARKINSON AGENT; CENTRAL MUSCLE RELAXANT;

ARTICLE; CATHETER; CEREBRAL PALSY; CERVICAL DYSTONIA; CLINICAL TRIAL; CONSTRAINT INDUCED THERAPY; DORSAL RHIZOTOMY; DROWSINESS; DYSESTHESIA; DYSTONIA; HUMAN; INFECTION; INFUSION PUMP; MUSCLE CONTRACTURE; MUSCLE NECROSIS; MUSCLE TONE; OCCUPATIONAL THERAPY; ORTHOPEDIC SURGERY; PAIN; PHYSIOTHERAPIST; SCOLIOSIS; SEDATION; SPINE MALFORMATION; SURGICAL TECHNIQUE; TREATMENT PLANNING; VASCULAR DISEASE; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOTHERAPY; REVIEW; RHIZOTOMY;

ADMINISTRATION, ORAL; ANTI-DYSKINESIA AGENTS; BACLOFEN; BOTULINUM TOXINS; CEREBRAL PALSY; HUMANS; MUSCLE RELAXANTS, CENTRAL; MUSCLE TONUS; ORTHOPEDIC PROCEDURES; PHENOL; PHYSICAL THERAPY MODALITIES; RHIZOTOMY;

EID: 33646143329     PISSN: 15455343     EISSN: 15455351     Source Type: Journal    
DOI: 10.1016/j.nurx.2006.01.008     Document Type: Article

References (67)

1. Surveillance of Cerebral Palsy in Europe (SCPE). Surveillance of cerebral palsy in Europe. a collaboration of cerebral palsy surveys and registers. Dev Med Child Neurol 42 (2000) 816-824
2. Pharoah P.O., Platt M.J., and Cooke T. The changing epidemiology of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 75 (1996) F169-F173
3. Bax M., Goldstein M., Rosenbaum P., Leviton A., Paneth N., Dan B., Jacobsson B., and Damiano D. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol 47 (2005) 571-576
4. Nelson K.B., and Ellenberg J.H. Epidemiology of cerebral palsy. Adv Neurol 19 (1978) 421-435
5. Sanger T.D., Delgado M.R., Gaebler-Spira D., Hallett M., and Mink J.W. Classification and definition of disorders causing hypertonia in childhood. Pediatrics 111 (2003) e89-e97
6. Mayer N.H. Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motor neuron lesion. In: Mayer N.H., and Simpson D.M. (Eds). Spasticity. etiology, evaluation, management, and the role of botulinum toxin (2002), WE MOVE, New York 1-15
7. Russman B.S., Tilton A., and Gormley Jr. M.E. Cerebral palsy. a rational approach to a treatment protocol, and the role of botulinum toxin in treatment. Muscle Nerve Suppl 6 (1997) S181-S193
8. Lance J.W. Symposium synopsis. In: Feldman R.G., Young R.R., and Koella W.P. (Eds). Spasticity. disordered motor control (1980), Yearbook Medical, Chicago 485-494
9. Mayer N.H., and Herman R.M. Phenomenology of muscle overactivity in the upper motor neuron syndrome. In: Mayer N.H., and Pierson S.H. (Eds). Muscle overactivity in the upper motor neuron syndrome. the role of oral medications, a focus on dantrolene sodium (2004), WE MOVE, New York 1-25
10. Bohannon R.W., and Smith M.B. Interrater reliablity of a modified Ashworth scale of muscle spasticity. Phys Ther 67 (1986) 206-207
11. Reimers J. Clinically based decision-making for surgery. In: Sussman M.D. (Ed). The diplegic child evaluation and management (1991), American Academy of Orthopedic Surgeons, Rosemont, IL 151
12. Benda W., McGibbon N.H., and Grant K.L. Improvements in muscle symmetry in children with cerebral palsy after equine-assisted therapy (hippotherapy). J Altern Complement Med 9 (2003) 817-825
13. Dali C., Hansen F.J., Pedersen S.A., Skov L., Hilden J., Bjornskov I., Strandberg C., Jette C., Ulla H., Herbst G., and Ulla L. Threshold electrical stimulation (TES) in ambulant children with CP. a randomized double-blind placebo-controlled clinical trial. Dev Med Child Neurol 44 (2002) 364-369
14. Hakkennes S., and Keating J.L. Constraint-induced movement therapy following stroke. a systematic review of randomised controlled trials. Aust J Physiother 51 (2005) 221-231
15. Taub E., Ramey S.L., DeLuca S., and Echols K. Efficacy of constraint-induced movement therapy for children with cerebral palsy with asymmetric motor impairment. Pediatrics 113 (2004) 305-312
16. Damiano D.L., and Abel M.F. Functional outcomes of strength training in spastic cerebral palsy. Arch Phys Med Rehabil 79 (1998) 119-125
17. Dodd K.J., Taylor N.F., and Graham H.K. A randomized clinical trial of strength training in young people with cerebral palsy. Dev Med Child Neurol 45 (2003) 652-657
18. McBurney H., Taylor N.F., Dodd K.J., and Graham H.K. A qualitative analysis of the benefits of strength training for young people with cerebral palsy. Dev Med Child Neurol 45 (2003) 658-663
19. Carlson W.E., Vaughan C.L., Damiano D.L., and Abel M.F. Orthotic management of gait in spastic diplegia. Am J Phys Med Rehabil 76 (1997) 219-225
20. Wilson H., Haideri N., Song K., and Telford D. Ankle-foot orthoses for preambulatory children with spastic diplegia. J Pediatr Orthop 17 (1997) 370-376
21. Corry I.S., Cosgrove A.P., Duffy C.M., McNeill S., Taylor T.C., and Graham H.K. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus. a randomised prospective trial. J Pediatr Orthop 18 (1998) 304-311
22. Flett P.J., Stern L.M., Waddy H., Connell T.M., Seeger J.D., and Gibson S.K. Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy. J Paediatr Child Health 35 (1999) 71-77
23. Bottos M., Benedetti M.G., Salucci P., Gasparroni V., and Giannini S. Botulinum toxin with and without casting in ambulant children with spastic diplegia. a clinical and functional assessment. Dev Med Child Neurol 45 (2003) 758-762
24. Kay R.M., Rethlefsen S.A., Fern-Buneo A., Wren T.A., and Skaggs D.L. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy. J Bone Joint Surg Am 86A (2004) 2377-2384
25. Ackman J.D., Russman B.S., Thomas S.S., Buckon C.E., Sussman M.D., Masso P., et al. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Dev Med Child Neurol 47 (2005) 620-627
26. Gracies J.M., Nance P., Elovic E., McGuire J., and Simpson D.M. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Muscle Nerve Suppl 6 (1997) S92-S120
27. Mathew A., Mathew M.C., Thomas M., and Antonisamy B. The efficacy of diazepam in enhancing motor function in children with spastic cerebral palsy. J Trop Pediatr 51 (2005) 109-113
28. Holt K.S. The use of diazepam in childhood cerebral palsy. report of a small study including electromyographic observations. Ann Phys Med Suppl (1964) 16-24
29. Engle H.A. The effect of diazepam (Valium) in children with cerebral palsy. a double-blind study. Dev Med Child Neurol 8 (1966) 661-667
30. Dahlin M., Knutsson E., and Nergardh A. Treatment of spasticity in children with low dose benzodiazepine. J Neurol Sci 117 (1993) 54-60
31. Milla P.J., and Jackson A.D. A controlled trial of baclofen in children with cerebral palsy. J Int Med Res 5 (1977) 398-404
32. Brin I.L., Kurenkov A.L., and Gotlib V.I. [The use of sirdalud in cerebral palsy in children]. Zh Nevrol Psikhiatr Im S S Korsakova 99 (1999) 30-33
33. Joynt R.L., and Leonard Jr. J.A. Dantrolene sodium suspension in treatment of spastic cerebral palsy. Dev Med Child Neurol 22 (1980) 755-767
34. Nogen A.G. Medical treatment for spasticity in children with cerebral palsy. Childs Brain 2 (1976) 304-308
35. Chyatte S.B., Birdsong J.H., and Bergman B.A. The effects of dantrolene sodium on spasticity and motor performance in hemiplegia. South Med J 64 (1971) 180-185
36. Brin M.F., and Aoki K.R. Botulinum toxin type A. pharmacology. In: Mayer N.H., and Simpson D.M. (Eds). Spasticity. etiology, evaluation, management, and the role of botulinum toxin (2002), WE MOVE, New York 110-124
37. WE MOVE. 2005 Management of spasticity with botulinum toxin type A (BOTOX®) [Online] (2005) Accessed January 4, 2006.
38. Speth L.A., Leffers P., Janssen-Potten Y.J., and Vles J.S. Botulinum toxin A and upper limb functional skills in hemiparetic cerebral palsy. a randomized trial in children receiving intensive therapy. Dev Med Child Neurol 47 (2005) 468-473
39. Steenbeek D., Meester-Delver A., Becher J.G., and Lankhorst G.J. The effect of botulinum toxin type A treatment of the lower extremity on the level of functional abilities in children with cerebral palsy. evaluation with goal attainment scaling. Clin Rehabil 19 (2005) 274-282
40. Wallen M.A., O'Flaherty S.J., and Waugh M.C. Functional outcomes of intramuscular botulinum toxin type A in the upper limbs of children with cerebral palsy. a phase II trial. Arch Phys Med Rehabil 85 (2004) 192-200
41. Baker R., Jasinski M., Iag-Tymecka I., Michalowska-Mrozek J., Bonikowski M., Carr L., MacLean J., Lin J.P., Lynch B., Theologis T., Wendorff J., Eunson P., and Cosgrove A. Botulinum toxin treatment of spasticity in diplegic cerebral palsy. a randomized, double-blind, placebo-controlled, dose-ranging study. Dev Med Child Neurol 44 (2002) 666-675
42. Fehlings D., Rang M., Glazier J., and Steele C. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatr 137 (2000) 331-337
43. Sutherland D.H., Kaufman K.R., Wyatt M.P., Chambers H.G., and Mubarak S.J. Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture 10 (1999) 1-9
44. Corry I.S., Cosgrove A.P., Walsh E.G., McClean D., and Graham H.K. Botulinum toxin A in the hemiplegic upper limb. a double-blind trial. Dev Med Child Neurol 39 (1997) 185-193
45. Gracies J.M., Elovic E., McGuire J., and Simpson D.M. Traditional pharmacologic treatments for spasticity. Part I: local treatments. In: Mayer N.H., and Simpson D.M. (Eds). Spasticity. etiology, evaluation, management, and the role of botulinum toxin (2005), WE MOVE, New York 44-64
46. Wong A.M., Chen C.L., Chen C.P., Chou S.W., Chung C.Y., and Chen M.J. Clinical effects of botulinum toxin A and phenol block on gait in children with cerebral palsy. Am J Phys Med Rehabil 83 (2004) 284-291
47. Gooch J.L., and Patton C.P. Combining botulinum toxin and phenol to manage spasticity in children. Arch Phys Med Rehabil 85 (2004) 1121-1124
48. Albright A.L., Barron W.B., Fasick M.P., Polinko P., and Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 270 (1993) 2475-2477
49. Rawlins P.K. Intrathecal baclofen therapy over 10 years. J Neurosci Nurs 36 (2004) 322-327
50. Gilmartin R., Bruce D., Storrs B.B., Abbott R., Krach L., Ward J., Bloom K., Brooks W.H., Johnson D.L., Madsen J.R., McLaughlin J.F., and Nadell J. Intrathecal baclofen for management of spastic cerebral palsy. multicenter trial. J Child Neurol 15 (2000) 71-77
51. Van S.P., Nuttin B., Lagae L., Schrijvers E., Borghgraef C., and Feys P. Intrathecal baclofen for intractable cerebral spasticity. a prospective placebo-controlled, double-blind study. Neurosurgery 46 (2000) 603-609
52. Gerszten P.C., Albright A.L., and Barry M.J. Effect on ambulation of continuous intrathecal baclofen infusion. Pediatr Neurosurg 27 (1997) 40-44
53. Gerszten P.C., Albright A.L., and Johnstone G.F. Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. J Neurosurg 88 (1998) 1009-1013
54. Murphy N.A., Irwin M.C., and Hoff C. Intrathecal baclofen therapy in children with cerebral palsy. efficacy and complications. Arch Phys Med Rehabil 83 (2002) 1721-1725
55. Zuckerbraun N.S., Ferson S.S., Albright A.L., and Vogeley E. Intrathecal baclofen withdrawal. emergent recognition and management. Pediatr Emerg Care 20 (2004) 759-764
56. Darbari F.P., Melvin J.J., Piatt Jr. J.H., Adirim T.A., and Kothare S.V. Intrathecal baclofen overdose followed by withdrawal. clinical and EEG features. Pediatr Neurol 33 (2005) 373-377
57. Steinbok P. Outcomes after selective dorsal rhizotomy for spastic cerebral palsy. Childs Nerv Syst 17 (2001) 1-18
58. van Schie P.E., Vermeulen R.J., van Ouwerkerk W.J., Kwakkel G., and Becher J.G. Selective dorsal rhizotomy in cerebral palsy to improve functional abilities. evaluation of criteria for selection. Childs Nerv Syst 21 (2005) 451-457
59. Galarza M., Fowler E.G., Chipps L., Padden T.M., and Lazareff J.A. Functional assessment of children with cerebral palsy following limited (L4-S1) selective posterior rhizotomy-a preliminary report. Acta Neurochir (Wien) 143 (2001) 865-872
60. Wright F.V., Sheil E.M., Drake J.M., Wedge J.H., and Naumann S. Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy. a randomized controlled trial. Dev Med Child Neurol 40 (1998) 239-247
61. Steinbok P., Reiner A.M., Beauchamp R., Armstrong R.W., Cochrane D.D., and Kestle J. A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy. Dev Med Child Neurol 39 (1997) 178-184
62. McLaughlin J.F., Bjornson K.F., Astley S.J., Graubert C., Hays R.M., Roberts T.S., Price R., and Temkin N. Selective dorsal rhizotomy. efficacy and safety in an investigator-masked randomized clinical trial. Dev Med Child Neurol 40 (1998) 220-232
63. Engsberg J.R., Ross S.A., and Park T.S. Changes in ankle spasticity and strength following selective dorsal rhizotomy and physical therapy for spastic cerebral palsy. J Neurosurg 91 (1999) 727-732
64. Johnson M.B., Goldstein L., Thomas S.S., Piatt J., Aiona M., and Sussman M. Spinal deformity after selective dorsal rhizotomy in ambulatory patients with cerebral palsy. J Pediatr Orthop 24 (2004) 529-536
65. Steinbok P., Hicdonmez T., Sawatzky B., Beauchamp R., and Wickenheiser D. Spinal deformities after selective dorsal rhizotomy for spastic cerebral palsy. J Neurosurg 102 (2005) 363-373
66. Chicoine M.R., Park T.S., and Kaufman B.A. Selective dorsal rhizotomy and rates of orthopedic surgery in children with spastic cerebral palsy. J Neurosurg 86 (1997) 34-39
67. Hagglund G., Andersson S., Duppe H., Pedertsen H.L., Nordmark E., and Westbom L. Prevention of severe contractures might replace multilevel surgery in cerebral palsy. results of a population-based health care programme and new techniques to reduce spasticity. J Pediatr Orthop B 14 (2005) 269-273